Myszkowski Kenneth Allen 4
4 · ARROWHEAD PHARMACEUTICALS, INC. · Filed Jan 12, 2021
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2021-01-11$81.02/sh−11,597$939,589→ 445,446 total - Sale
Common Stock
2021-01-12$81.00/sh−1,441$116,721→ 444,005 total
Footnotes (1)
- [F1]The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.00 to $81.08, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.